AGG Talks: Healthcare Insights Podcast - Episode 2: Substance Use Disorder Litigation
Addiction and the Recovery Journey for Lawyers | Brian Cuban | Texas Appellate Law Podcast
DE Talk | Uncovering the Non-Traditional Workforce: Recruiting & Retaining Talent in Addiction Recovery
The Presumption of Innocence Podcast: Episode 22 - Reclaiming Purpose: A Transformative Journey Through Addiction, Rehab and Prison
Taking the Pulse, A Health Care and Life Sciences Podcast | Episode 105: Sara Goldsby, Director, DAODAS
Author Brian Cuban Talks About “The Addicted Lawyer” and the Addiction Crisis Among Lawyers: On Record PR
2019 Cannabis & Co: Family and Medical Leave Act (FMLA) in the Post Prop. 64 Era (Part 3)
Jones Day Talks Health Care: The Eliminating Kickbacks in Recovery Act
Veterans' Issues and How They May Impact Your Practice
The COVID-19 pandemic has coincided with worsening mental health across the country, and California is no exception. Not surprisingly, Governor Gavin Newsom signed into law multiple pieces of mental health treatment related...more
The Mental Health Parity and Addiction Equity Act (MHPAEA) requires health plans to provide equal levels of coverage for mental health conditions and substance use disorders (SUD) as for physical illnesses. Understanding and...more
Recognizing the urgent need to increase access to mental health and substance use services for young people, Congress is taking significant legislative steps to strengthen the federal government’s response to the nationwide...more
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector. ...more
There was a great deal of action under the Gold Dome on Tuesday, including the biennial “class” portrait in the House where they had their panoramic photo taken. Other notable news of the day included the Senate Republican...more
October 10th was the last day for Governor Newsom to sign or veto laws that were passed by the legislature this year. 2021 was a busy year for California legislators, who put forth hundreds of health-related bills in the wake...more
As COVID-19 vaccines continue to roll out across the county, there is uncertainty as to whether certain telehealth laws that significantly impacted healthcare providers, payors and patients during the public health emergency...more
A bipartisan pair of US senators have proposed legislation that would allow certain controlled substances to be prescribed via an initial telehealth encounter and—under certain conditions—expand Medicare reimbursement of...more
... Massachusetts House Bill 4134 includes several provisions aimed at expanding access to treatment for mental health and substance use conditions in the Massachusetts Commonwealth. Most notably, the Bill would require...more
This episode is the first in a series focusing on recent efforts by the Substance Abuse and Mental Health Services Administration (SAMHSA) to update 42 C.F.R. Part 2 (Part 2) regulations related to the confidentiality of...more
A workgroup report reviewed in the House Human Services Committee this week recommended that Vermont consider implementing an unused drug repository program....more
Panel passes substance abuse prevention bill - The Senate Health and Welfare committee voted out a committee bill relating to substance misuse prevention on Friday. The bill proposes to establish a Substance Misuse...more
Last week, the United States Congress passed a 250-page bill addressing the opioid crisis entitled SUPPORT for Patients and Communities Act (the “Opioid Act”). However, at page 56 of the Opioid Act, there is a short section...more
On October 3, 2018, the Senate voted 98-1 to pass a compromise opioids response package that includes key provisions to expand telehealth coverage and reimbursement. The House had previously passed the opioids agreement...more
House and Senate leaders Wednesday agreed to sweeping new legislation to respond to the national opioid epidemic, including authorizing $8 billion in grant programs for states, expanding access to prevention and treatment,...more
Given broad interest in addressing opioid abuse and growing public pressure, lawmakers have considered a broad range of bills designed to address opioids, intending to pass legislation during the summer to demonstrate action...more
Our series highlighting recent activity by the NYS Legislature continues with a recap of bills passed in 2018 that relate to behavioral health. This synopsis follows previous summaries we have done concerning pharmacy,...more
On June 22 the U.S. House of Representatives passed sweeping legislation that represents "the biggest effort Congress has ever undertaken" to address the opioid epidemic, according to Rep. Greg Walden (R-OR). The House...more
Foley & Lardner LLP’s (“Foley”) Bipartisan Public Policy Team is pleased to share our “Public Policy Weekly* Health Care Newsletter” in which we compile the latest Health care policy news and legislation. *Please note that we...more
Given broad interest in addressing opioid abuse and growing public pressure, both the House and Senate are considering a broad range of bills designed to address opioids, with lawmakers working to pass legislation during the...more
The multi-year effort to address the addiction crisis, specifically opiates in recent years, continues in earnest. Some policies do seem to be working: as reported by Delaware officials in April, opiate prescriptions are down...more
As part of the 2018-2019 New York State Budget, the Governor and the Legislature have agreed to a package of legislation addressing the opioid crisis in New York that includes requiring opioid manufacturers and distributors...more
As stories and statistics of the opioid crisis become increasingly prevalent in our national discourse, we are seeing a stronger, more innovative, and more aligned push for interventions across communities, government...more
Several states have proposed and enacted new laws to address the opioid crisis, including laws that focus on reducing financial incentives that drug manufacturers can give to providers. Most recently, New Jersey Governor...more